Page last updated: 2024-09-03

bw 245c and transforming growth factor beta

bw 245c has been researched along with transforming growth factor beta in 2 studies

Compound Research Comparison

Studies
(bw 245c)
Trials
(bw 245c)
Recent Studies (post-2010)
(bw 245c)
Studies
(transforming growth factor beta)
Trials
(transforming growth factor beta)
Recent Studies (post-2010) (transforming growth factor beta)
9631049,11956017,610

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huaux, F; Lison, D; Uwambayinema, F; van den Brule, S; Wallemme, L1
Ayabe, S; Hori, M; Kida, T; Murata, T; Ozaki, H1

Other Studies

2 other study(ies) available for bw 245c and transforming growth factor beta

ArticleYear
The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:2

    Topics: Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Proliferation; Cells, Cultured; Collagen; Female; Fibroblasts; Humans; Hydantoins; Interleukin-13; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Receptors, Prostaglandin; Transforming Growth Factor beta

2010
Prostaglandin D2 inhibits collagen secretion from lung fibroblasts by activating the DP receptor.
    Journal of pharmacological sciences, 2013, Volume: 121, Issue:4

    Topics: Cells, Cultured; Collagen; Cyclic AMP; Fibroblasts; Humans; Hydantoins; Lung; Prostaglandin D2; Receptors, Immunologic; Receptors, Prostaglandin; Transforming Growth Factor beta

2013